Achieve Life Sciences (ACHV) Revenue (2011 - 2013)

Achieve Life Sciences (ACHV) recorded quarterly Revenue of $6.3 million in Q2 2013, up 23.53% on a QoQ basis from $5.1 million in Q1 2013, and up 162.5% year-over-year from $2.4 million in Q2 2012.

Achieve Life Sciences (ACHV) Revenue (2011 - 2013) Analysis & Trends

Achieve Life Sciences has disclosed Revenue across 3 years of filings, most recently posting $6.3 million for Q2 2013.

  • Quarterly Revenue rose 162.5% year-over-year to $6.3 million in Q2 2013, while the trailing twelve-month figure through Jun 2013 was $27.8 million (up 355.74% YoY) and the FY2012 annual result came in at $20.1 million, up 265.45% from the prior year.
  • Revenue grew to $6.3 million in Q2 2013, from $5.1 million in the prior quarter.
  • Over five years, Revenue peaked at $9.8 million in Q4 2012 and troughed at $1.2 million in Q3 2011.
  • A 3-year average of $4.0 million and a median of $2.4 million in 2012 frame the typical range for Revenue.
  • Biggest YoY gain for Revenue was 716.67% in 2012; the steepest drop was 26.32% in 2012.
  • Tracing ACHV's Revenue over 3 years: stood at $1.2 million in 2011, then jumped by 716.67% to $9.8 million in 2012, then sank by 35.71% to $6.3 million in 2013.
  • Business Quant data shows ACHV's Revenue at $6.3 million in Q2 2013, $5.1 million in Q1 2013, and $9.8 million in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 5.21 Mn
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 306.30 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.71 Bn 91.71 Bn - -
10 Achieve Life Sciences 93.71 Mn 63.22 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2013 6.30 Mn
Mar 31, 2013 5.10 Mn
Dec 31, 2012 9.80 Mn
Sep 30, 2012 6.60 Mn
Jun 30, 2012 2.40 Mn
Mar 31, 2012 1.30 Mn
Dec 31, 2011 1.20 Mn
Sep 30, 2011 1.20 Mn
Jun 30, 2011 1.90 Mn